Novo Nordisk (NYSE:NVO) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsMike Doustdar - CEOConference Call ParticipantsRichard Vosser - European Pharma AnalystRichard VosserWelcome to the Novo Nordisk session at the 26th J.P. Morgan Healthcare Conference. I'm Richard Vosser, European Pharma Analyst at J.P. Morgan, and it's my great pleasure to welcome the new CEO of Novo, Mike Doustdar. He's been CEO for about five months and has been spending that time looking at the strategy, revising the s ...